Clinical Trial Update: A Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis Bullosa [Phase 4]

View source ↗

Summary

An observational Phase 4 trial evaluating Apligraf for nonhealing wounds in patients with Epidermolysis Bullosa has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa

Drugs mentioned

• Apligraf

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Epidermolysis Bullosa, Wound Healing | Phase 4 | Status: TERMINATED